Covid-19 roundup: As­traZeneca team finds a sur­prise Covid-19 vac­cine part­ner; Bio­gen con­fer­ence linked to 300K cas­es

With ques­tions still swirling over its Covid-19 vac­cine’s true ef­fi­ca­cy, As­traZeneca is pur­su­ing a sur­pris­ing ap­proach: com­bin­ing their ade­n­ovirus vac­cine with the Russ­ian-backed Sput­nik V …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.